DXCM DexCom, Inc. - Common Stock
$90,75
Prezzo · Ago 18, 2026
Fondamentali al Lug 30, 2026
Intervallo 52 sett.
$54–$92
97% of range
Rating Analisti
BUY
36 analysts
Prezzo Obiettivo
$93
+3% upside
P/E (TTM)
43.5
ROE
31.4%
Margine di Profitto Netto
17.9%
Informazioni su DexCom, Inc. - Common Stock Panoramica della società da Wikipedia
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
Leggi di più
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
History
Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours. Dexcom received approval of the second-generation product, the Seven Continuous Glucose Monitoring System, in May 2007. This device improved on accuracy and extended use from three to seven days. In 2008, Dexcom announced two consumer development agreements with Insulet Corporation and Animas Corporation as well as a development agreement with Edwards Lifesciences for a continuous glucose monitor in the intensive care unit hospital environment.
During February 2009, Dexcom received approval for the Seven Plus Continuous Glucose Monitor, its new continuous glucose monitoring system, from the FDA. This product received a CE mark in November 2009. In 2013, development work for integration with Insulet was discontinued. Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its forthcoming G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. The G5 was approved in 2016 by the FDA for use as a standalone device, while the G6 gained approval in 2018.
Dexcom's first G-series CGM, the G4 Platinum, received a CE mark and FDA approval in 2012 for adults ages 18 and over. This device improved hypoglycemic accuracy by 30%. It also offered a longer range of transmission between the sensor and receiver, as well as a color LCD. The G4 Platinum was approved by the FDA for use in patients ages 2–17 in February 2014. Dexcom received FDA approval in January 2015 for the G4 Platinum with Share, which enabled the sharing of CGM data with up to five other people using the "Share" and "Follow" smartphone apps.
The Dexcom G5 was approved in August 2015 by the FDA for use as a standalone device, the G5 has Bluetooth integrated into its transmitter, enabling it to send data to a mobile device. This allows for use of the device without the standalone receiver. The Dexcom G5 received a CE mark in September 2015.
Dexcom went public in 2005 and is listed on the Nasdaq Global Select Market stock exchange under the ticker symbol DXCM. On April 20, 2020, Dexcom became a component of the Nasdaq-100, replacing American Airlines Group in the index.
The Dexcom G7 was approved in December 2022 by the FDA for use as a standalone device. The Dexcom G7 15-Day is the most accurate currently approved CGM in the U.S.
Awards and recognition
In October 2024, Time Magazine named Dexcom Stelo's over-the-counter glucose monitor one of the year's best inventions.
Partnerships
Dexcom entered into a partnership in 2015 with Google Life Sciences (which subsequently became Verily) to develop the Dexcom G7
Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its new G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. Tandem Diabetes Care received FDA approval in December 2019 for Control-IQ, a closed-loop technology that uses Tandem's t:slim X2 insulin pump and the Dexcom G6 "to automatically increase, decrease, or stop the delivery of insulin in response to the glucose levels of people with Type 1 diabetes."
In June 2019, Dexcom announced a collaboration with Companion Medical to enable the exchange of CGM data from Dexcom with insulin data from InPen into both companies' software applications.
Dexcom entered into a partnership with Livongo, a digital chronic care management company, in January 2020 to share CGM data from the Dexcom G6 with Livongo's platform. This integration allowed Livongo to incorporate the CGM data along with other patient data.
In February 2020, Dexcom and Insulet Corporation signed a non-exclusive, global agreement to combine current and future Dexcom continuous glucose monitoring systems with Insulet's tubeless insulin delivery Pod into the Omnipod Horizon System for automated insulin delivery. This allowed the ability to adjust insulin doses based on Insulet's algorithm or through their smartphone.
The company also announced in March 2020 a partnership with Welldoc to integrate G6 CGM data with BlueStar, a digital platform for diabetes management.
In November 2024, Dexcom announced a "strategic partnership" and data exchange with Oura.
Venture capital arm
In early 2021, Dexcom launched Dexcom Ventures, a venture capital arm focused on emerging continuous glucose monitoring technologies and devices measuring the levels of other types of substances and analytes. In practice, Dexcom Ventures has also invested in cybersecurity platforms for the software used in medical devices.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
DXCM Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$90.75
Capitalizzazione di Mercato
$35.02B
P/E (TTM)
43.5
EPS (TTM)
$2.09
Ricavi (TTM)
$4.66B
Rendimento div.
—
ROE
31.4%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$54 – $92
DXCM Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$4.66B
2016-12-31
→
2025-12-31
EPS
$2.09
2017-12-31
→
2025-12-31
Flusso di cassa libero
$1.08B
2016-12-31
→
2025-12-31
Margini
17.9%
2018-12-31
→
2025-12-31
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
DXCM
Mediana dei peer
P/E (TTM)
43.5
26.3
P/S (TTM)
7.5
4.4
P/B
12.8
5.3
Price / FCF (Prezzo / FCF)
32.5
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
DXCM
Mediana dei peer
Gross Margin (Margine lordo)
60.1%
63.1%
Operating Margin (Margine Operativo)
19.6%
—
Net Profit Margin (Margine di Profitto Netto)
17.9%
15.6%
ROA
13.0%
7.6%
ROE
31.4%
15.0%
ROIC
25.5%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
DXCM
Mediana dei peer
Current Ratio (Rapporto corrente)
1.9
1.7
Quick Ratio
1.0
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
DXCM
Mediana dei peer
Revenue YoY (Ricavi YoY)
15.6%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
17.0%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
19.3%
—
EPS YoY
47.2%
—
Net Income YoY (Utile Netto YoY)
45.1%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
DXCM
Mediana dei peer
DXCM Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
36 analisti
- Acquisto forte 15 41,7%
- Compra 16 44,4%
- Mantieni 5 13,9%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
25 analisti · 2026-08-14
Mediana
$93.00
Ora
$90.75
Basso
$79.00
Alto
$115.00
Target mediano
$93.00
+2,5%
Target medio
$93.44
+3,0%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.05%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $0.70 | $0.62 | 0.08% |
| 31 Marzo 2026 | $0.56 | $0.48 | 0.08% |
| 31 Dicembre 2025 | $0.56 | $0.48 | 0.08% |
| 30 Settembre 2025 | $0.61 | $0.58 | 0.03% |
| 30 Giugno 2025 | $0.48 | $0.45 | 0.03% |
| 31 Marzo 2025 | $0.32 | $0.33 | -0.01% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 18
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | · | · | |
| Cost of Revenue | $1.86B | $1.59B | $1.33B | $1.03B | $768M | $647M | $544M | $368M | $226M | $195M | $124M | $83M | |
| Gross Profit | $2.80B | $2.44B | $2.29B | $1.88B | $1.68B | $1.28B | $932M | $664M | $492M | $378M | $278M | $176M | |
| R&D Expense | $599M | $552M | $506M | $484M | $517M | $360M | $274M | $200M | $185M | $156M | $138M | $69M | |
| SG&A Expense | $1.29B | $1.29B | $1.19B | $1.01B | $810M | $618M | $516M | $433M | $349M | $286M | $198M | $128M | |
| Operating Expenses | $1.89B | $1.84B | $1.69B | $1.49B | $1.41B | $981M | $789M | $850M | $535M | $442M | $336M | $198M | |
| Operating Income | $912M | $600M | $598M | $391M | $266M | $300M | $142M | $-186M | $-42M | $-64M | $-57M | $-22M | |
| Interest Expense | · | · | $20M | $19M | $19M | $18M | $60M | $23M | $13M | $700.0K | $400.0K | $800.0K | |
| Interest Income | · | · | · | · | · | · | · | · | $3M | $400.0K | $0 | $0 | |
| Other Non-op | $177M | $109M | $113M | $-400.0K | $-9M | $16M | $26M | $2M | $7M | $-700.0K | $0 | $0 | |
| Pretax Income | $1.09B | $709M | $710M | $391M | $257M | $298M | $104M | $-126M | $-49M | $-65M | $-58M | $-22M | |
| Income Tax | $252M | $133M | $169M | $50M | $40M | $-252M | $3M | $600.0K | $2M | $700.0K | $100.0K | $100.0K | |
| Net Income | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| EPS (Basic) | $2.14 | $1.46 | $1.40 | $0.88 | $0.56 | $1.46 | $1.11 | $-1.44 | $-0.58 | · | · | · | |
| EPS (Diluted) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $1.10 | $-1.44 | $-0.58 | · | · | · | |
| Shares (Basic) | 390,200,000 | 393,600,000 | 386,000,000 | 389,400,000 | 386,900,000 | 377,500,000 | 91,100,000 | 88,200,000 | 86,300,000 | · | · | · | |
| Shares (Diluted) | 405,500,000 | 412,700,000 | 425,500,000 | 427,500,000 | 428,800,000 | 420,400,000 | 92,300,000 | 88,200,000 | 86,300,000 | · | · | · | |
| EBITDA | $1.16B | $818M | $784M | $547M | $368M | $367M | $191M | $-157M | $-26M | $-49M | $-46M | $-13M |
Stato Patrimoniale 26
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $918M | $606M | $566M | $642M | $1.05B | $818M | $446M | $1.14B | $442M | $94M | $86M | $72M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $93M | $23M | · | · | |
| Receivables | $1.22B | $1.01B | $974M | $713M | $514M | $428M | $286M | $227M | $134M | $102M | $74M | $42M | |
| Inventory | $629M | $543M | $560M | $307M | $357M | $235M | $120M | $71M | $45M | $45M | $35M | $16M | |
| Prepaid Expense | $189M | $174M | $168M | $193M | $82M | $54M | $30M | $16M | $17M | $9M | $7M | $4M | |
| Other Current Assets | $29M | $29M | $49M | $27M | $27M | · | · | · | · | · | · | · | |
| Current Assets | $4.03B | $4.30B | $4.43B | $3.67B | $3.68B | $3.42B | $1.97B | $1.70B | $745M | $280M | $231M | $146M | |
| PP&E (Net) | · | · | · | $1.06B | $802M | $515M | $321M | $183M | $146M | $109M | $55M | $31M | |
| PP&E (Gross) | · | · | · | $1.42B | $1.03B | $670M | $426M | $263M | $200M | $157M | $93M | $64M | |
| Accum. Depreciation | · | · | · | $363M | $232M | $154M | $105M | $80M | $55M | $47M | $38M | $33M | |
| Goodwill | $24M | $23M | $25M | $26M | $26M | $19M | $19M | $19M | $12M | $11M | $4M | $3M | |
| Intangibles | $71M | $103M | $134M | $173M | $32M | · | · | · | · | $200.0K | $2M | $3M | |
| Other Non-current Assets | $279M | $173M | $75M | $47M | $10M | $21M | $14M | $15M | $2M | $2M | $100.0K | $600.0K | |
| Total Assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Current Liabilities | $2.14B | $2.93B | $1.56B | $1.84B | $721M | $614M | $360M | $222M | $139M | $102M | $67M | $41M | |
| Capital Leases | $73M | $65M | $80M | $95M | $99M | $102M | $72M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | $5M | $6M | $0 | · | · | · | · | · | · | |
| Other Non-current Liabilities | $137M | $148M | $126M | $128M | $90M | $81M | $20M | $20M | $18M | $17M | $4M | $2M | |
| Total Liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.89B | $2.46B | $1.51B | $1.25B | $485M | $119M | $71M | $44M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Retained Earnings | $2.43B | $1.60B | $1.02B | $480M | $139M | $-78M | $-696M | $-799M | $-672M | $-621M | $-555M | $-498M | |
| Treasury Stock | $2.08B | $1.58B | $2.45B | $595M | $206M | $100M | $100M | $100M | $0 | · | · | · | |
| AOCI | $115M | $-8M | $-17M | $-12M | $500.0K | $3M | $2M | $2M | $-3M | $-1M | $-300.0K | $-100.0K | |
| Stockholders' Equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.04B | $1.55B | $883M | $663M | $419M | $284M | $221M | $140M | |
| Liabilities + Equity | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Shares Outstanding | 384,800,000 | 390,700,000 | 385,400,000 | 386,300,000 | 388,000,000 | 384,400,000 | 366,400,000 | 90,000,000 | 87,000,000 | 84,600,000 | 81,700,000 | 77,300,000 |
Flusso di cassa 19
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $252M | $218M | $186M | $156M | $102M | $67M | $49M | $29M | $16M | $15M | $11M | $8M | |
| Stock-based Comp | $160M | $170M | $151M | $126M | $113M | $119M | $103M | $102M | $106M | $111M | $83M | $50M | |
| Deferred Tax | $182M | $-44M | $-55M | $-22M | $16M | $-260M | $200.0K | $-2M | $0 | $-200.0K | $0 | $0 | |
| Amort. of Intangibles | $4M | $7M | $8M | $8M | $4M | $2M | · | · | · | $700.0K | $500.0K | $600.0K | |
| Restructuring | · | · | · | · | · | · | $8M | · | · | · | · | · | |
| Other Non-cash | $11M | $69M | $-75M | $68M | $77M | $73M | $62M | $122M | $20M | $-4M | $13M | $-12M | |
| Operating Cash Flow | $1.44B | $990M | $748M | $670M | $442M | $476M | $314M | $123M | $92M | $56M | $49M | $24M | |
| CapEx | $364M | $359M | $237M | $365M | $389M | $199M | $180M | $67M | $66M | $56M | $33M | $16M | |
| Investing Cash Flow | $536M | $-208M | $-507M | $-522M | $-216M | $-1.02B | $-1.02B | $-140M | $-144M | $-56M | $-52M | $-17M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $0 | $-2M | $-2M | $-2M | |
| Stock Issued | $28M | $28M | $27M | $22M | $20M | $15M | $12M | $11M | $10M | $10M | $19M | $24M | |
| Stock Repurchased | $500M | $750M | $689M | $558M | $0 | $0 | $0 | $100M | $0 | $0 | · | · | |
| Net Stock Activity | $-472M | $-722M | $-662M | $-535M | $20M | $15M | $12M | $-89M | $10M | $10M | $19M | $24M | |
| Financing Cash Flow | $-1.69B | $-735M | $-319M | $-552M | $10M | $912M | $11M | $710M | $399M | $8M | $17M | $22M | |
| Net Change in Cash | $312M | $40M | $-76M | $-410M | $235M | $372M | $-691M | $696M | $347M | $8M | $14M | $29M | |
| Taxes Paid | $94M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.08B | $631M | $512M | $305M | $53M | $277M | $134M | $56M | $26M | $500.0K | $16M | $7M | |
| Levered FCF | · | · | $496M | $288M | $-36M | $91M | $76M | $33M | $13M | $-207.6K | $15M | $7M |
Redditività 8
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% | 66.4% | 63.1% | 64.4% | · | · | · | · | |
| Operating Margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% | 15.5% | 9.6% | -18.1% | · | · | · | · | |
| Net Margin | 17.9% | 14.3% | 14.9% | 11.7% | 6.3% | 25.6% | 6.9% | -12.3% | · | · | · | · | |
| Pretax Margin | 23.4% | 17.6% | 19.6% | 13.4% | 7.1% | 11.7% | 7.1% | -12.3% | · | · | · | · | |
| EBITDA Margin | 25.0% | 20.3% | 21.6% | 18.8% | 15.0% | 19.0% | 12.9% | -15.2% | · | · | · | · | |
| ROA | 13.0% | 9.0% | 9.3% | 6.6% | 3.4% | 14.8% | 4.7% | -9.0% | -7.7% | -18.9% | -24.2% | -14.6% | |
| ROE | 31.4% | 28.2% | 25.0% | 17.2% | 7.4% | 29.7% | 12.3% | -20.7% | -14.3% | -26.0% | -31.9% | -20.0% | |
| ROIC | 25.5% | 23.2% | 22.0% | 16.0% | 10.5% | 36.0% | 15.6% | -28.2% | -10.5% | -22.8% | -25.9% | -15.4% |
Liquidità e Solvibilità 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 | 5.6 | 5.5 | 7.6 | 5.4 | 2.7 | 3.5 | 3.6 | |
| Quick Ratio | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 | 2.0 | 2.0 | 6.1 | 4.8 | 2.1 | 2.4 | 1.8 | |
| Interest Coverage | · | · | 29.4 | 21.0 | 2.6 | 3.5 | 2.4 | -8.2 | -3.3 | -91.3 | -142.8 | -26.9 |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | · | · | · | · | |
| Inventory Turnover | 3.2 | 2.9 | 3.1 | 3.1 | 2.6 | 3.6 | 5.7 | 6.3 | 5.0 | 4.8 | 4.8 | 6.6 | |
| Receivables Turnover | 4.2 | 4.1 | 4.3 | 4.7 | 5.2 | 5.4 | 5.8 | 5.7 | · | · | · | · |
Tassi di Crescita 9
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 15.6% | 11.3% | 24.5% | 18.8% | 27.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 17.0% | 18.1% | 23.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 47.2% | 9.2% | 58.5% | 54.7% | -60.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 36.6% | 38.9% | -0.76% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 45.1% | 6.4% | 58.7% | 57.3% | -60.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 34.8% | 38.5% | -0.50% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 8.8% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | $402M | $259M | |
| Net Income TTM | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| Market Cap | $25.54B | $30.38B | $47.82B | $43.74B | $13.02B | $8.88B | $5.01B | $2.70B | $1.25B | $1.26B | $1.67B | $1.06B | |
| P/E | 31.8 | 54.8 | 95.5 | 138.1 | 253.3 | 69.5 | 49.7 | -20.8 | -24.7 | · | · | · | |
| P/S | 5.5 | 7.5 | 13.2 | 15.0 | 5.3 | 4.6 | 3.4 | 2.6 | 1.7 | 2.2 | 4.2 | 4.1 | |
| P/B | 9.3 | 14.5 | 23.1 | 20.5 | 5.8 | 4.9 | 5.7 | 4.1 | 3.0 | 4.4 | 7.6 | 7.6 | |
| P / Tangible Book | 9.6 | 15.4 | 25.1 | 22.6 | 6.6 | 5.8 | · | · | · | · | · | · | |
| P / Cash Flow | 17.7 | 30.7 | 63.9 | 65.3 | 29.4 | 18.7 | 15.9 | 21.9 | 13.6 | 22.5 | 34.1 | 45.1 | |
| P / FCF | 23.7 | 48.2 | 93.4 | 143.6 | 244.3 | 32.1 | 37.2 | 48.0 | 48.0 | 2525.3 | 106.5 | 143.8 | |
| Earnings Yield | 3.1% | 1.8% | 1.1% | 0.72% | 0.39% | 1.4% | 2.0% | -4.8% | -4.0% | · | · | · |
Conto Economico 17
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B | $1.04B | $1.11B | $994M | $1.00B | $921M | $1.03B | $975M | $871M | $742M | $815M | $770M | |
| Cost of Revenue | $478M | $442M | $467M | $478M | $468M | $447M | $458M | $400M | $378M | $359M | $378M | $352M | $325M | $279M | $274M | $275M | |
| Gross Profit | $830M | $750M | $793M | $731M | $689M | $589M | $656M | $594M | $627M | $562M | $657M | $623M | $546M | $463M | $541M | $494M | |
| R&D Expense | $153M | $145M | $148M | $158M | $148M | $145M | $140M | $135M | $136M | $142M | $136M | $131M | $119M | $119M | $116M | $110M | |
| SG&A Expense | $359M | $350M | $322M | $331M | $328M | $310M | $327M | $306M | $333M | $319M | $304M | $286M | $299M | $296M | $305M | $235M | |
| Operating Expenses | $512M | $495M | $470M | $489M | $476M | $455M | $467M | $442M | $469M | $461M | $440M | $418M | $418M | $415M | $416M | $347M | |
| Operating Income | $318M | $255M | $323M | $242M | $213M | $134M | $189M | $152M | $158M | $101M | $217M | $206M | $128M | $47M | $125M | $148M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $5M | · | $5M | $6M | $5M | · | $5M | |
| Other Non-op | $-800.0K | $14M | $18M | $110M | $28M | $21M | $22M | $25M | $30M | $31M | $29M | $35M | $31M | $17M | $-1M | $-1M | |
| Pretax Income | $318M | $270M | $341M | $352M | $241M | $154M | $211M | $177M | $188M | $132M | $246M | $240M | $159M | $64M | $133M | $146M | |
| Income Tax | $68M | $70M | $73M | $68M | $61M | $49M | $60M | $43M | $44M | $-14M | $-10M | $120M | $43M | $16M | $41M | $45M | |
| Net Income | $249M | $200M | $267M | $284M | $180M | $105M | $152M | $135M | $144M | $146M | $256M | $121M | $116M | $49M | $92M | $101M | |
| EPS (Basic) | $0.65 | $0.52 | $0.68 | $0.73 | $0.46 | $0.27 | $0.38 | $0.34 | $0.36 | $0.38 | $0.66 | $0.31 | $0.30 | $0.13 | $0.24 | $0.26 | |
| EPS (Diluted) | $0.64 | $0.51 | $0.67 | $0.70 | $0.45 | $0.27 | $0.37 | $0.34 | $0.35 | $0.36 | $0.61 | $0.29 | $0.28 | $0.12 | $0.23 | $0.24 | |
| Shares (Basic) | 382,200,000 | 385,100,000 | -784,100,000 | 391,100,000 | 392,100,000 | 391,100,000 | -790,000,000 | 394,200,000 | 399,200,000 | 390,200,000 | -774,000,000 | 386,600,000 | 386,700,000 | 386,700,000 | -781,800,000 | 389,800,000 | |
| Shares (Diluted) | 390,100,000 | 393,600,000 | -817,600,000 | 407,400,000 | 408,200,000 | 407,500,000 | -831,000,000 | 410,200,000 | 416,800,000 | 416,700,000 | -851,300,000 | 426,800,000 | 431,500,000 | 418,500,000 | -848,400,000 | 425,800,000 | |
| EBITDA | $386M | $322M | · | $306M | $276M | $194M | · | $152M | $158M | $154M | · | $206M | $128M | $89M | · | $148M |
Stato Patrimoniale 24
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.12B | $918M | $1.84B | $1.16B | $905M | $606M | $621M | $939M | $851M | $566M | $644M | $1.19B | $623M | $642M | $698M | |
| Receivables | $1.26B | $1.09B | $1.22B | $1.11B | $1.35B | $1.16B | $1.01B | $1.00B | $945M | $979M | · | $786M | $751M | $637M | · | $564M | |
| Inventory | $726M | $694M | $629M | $604M | $571M | $538M | $543M | $586M | $570M | $589M | · | $499M | $421M | $366M | · | $311M | |
| Prepaid Expense | $156M | $134M | $189M | $184M | $181M | $159M | $174M | $182M | $212M | $156M | · | $174M | $195M | $198M | · | $152M | |
| Other Current Assets | $37M | $30M | $29M | $34M | $46M | $43M | $29M | $48M | $48M | $40M | · | $41M | $58M | $43M | · | $28M | |
| Current Assets | $4.09B | $4.33B | $4.03B | $5.22B | $5.03B | $4.55B | $4.30B | $4.26B | $4.85B | $4.62B | · | $4.70B | $5.00B | $3.77B | · | $3.40B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.08B | · | $1.00B | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.47B | · | $1.34B | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $394M | · | $338M | |
| Goodwill | $24M | $24M | $24M | $24M | $24M | $23M | $23M | $24M | $23M | $23M | · | $25M | $26M | $26M | · | $25M | |
| Intangibles | $102M | $63M | $71M | $79M | $87M | $95M | $103M | $106M | $114M | $123M | · | $144M | $154M | $164M | · | $24M | |
| Other Non-current Assets | $274M | $286M | $279M | $276M | $176M | $168M | $173M | $88M | $83M | $78M | · | $74M | $67M | $57M | · | $34M | |
| Total Assets | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Current Liabilities | $2.36B | $2.22B | $2.14B | $3.34B | $3.31B | $3.04B | $2.93B | $1.73B | $1.72B | $1.59B | · | $1.68B | $2.07B | $1.86B | · | $900M | |
| Capital Leases | $83M | $69M | $73M | $51M | $55M | $60M | $65M | $71M | $77M | $76M | · | $83M | $87M | $90M | · | $82M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $151M | $142M | $137M | $147M | $152M | $150M | $148M | $130M | $128M | $129M | · | $134M | $133M | $130M | · | $123M | |
| Total Liabilities | $3.83B | $3.68B | $3.59B | $4.77B | $4.75B | $4.49B | $4.38B | $4.37B | $4.36B | $4.24B | · | $4.33B | $4.72B | $3.28B | · | $3.07B | |
| Retained Earnings | $2.88B | $2.63B | $2.43B | $2.17B | $1.88B | $1.70B | $1.60B | $1.45B | $1.31B | $1.17B | · | $765M | $644M | $528M | · | $388M | |
| Treasury Stock | $2.73B | $2.12B | $2.08B | $1.77B | $1.58B | $1.58B | $1.58B | $1.58B | $832M | $1.39B | · | $2.08B | $784M | $595M | · | $595M | |
| AOCI | $90M | $106M | $115M | $82M | $84M | $2M | $-8M | $63M | $-38M | $-37M | · | $-36M | $-29M | $-6M | · | $-41M | |
| Stockholders' Equity | $2.62B | $2.96B | $2.75B | $2.73B | $2.57B | $2.27B | $2.10B | $1.98B | $2.43B | $2.25B | $2.07B | $2.27B | $2.10B | $2.23B | $2.13B | $1.82B | |
| Liabilities + Equity | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Shares Outstanding | 377,400,000 | 385,900,000 | 384,800,000 | 390,000,000 | 392,200,000 | 392,100,000 | 390,700,000 | 390,600,000 | 400,700,000 | 396,100,000 | 385,400,000 | 386,400,000 | 386,100,000 | 387,600,000 | 386,300,000 | 386,200,000 |
Flusso di cassa 15
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $68M | $67M | $65M | $64M | $63M | $60M | $58M | $55M | $52M | $52M | $52M | $48M | $44M | $42M | $36M | $39M | |
| Stock-based Comp | $39M | $43M | $35M | $45M | $45M | $34M | $43M | $43M | $45M | $39M | $37M | $39M | $40M | $35M | $34M | $31M | |
| Deferred Tax | $-300.0K | $300.0K | $79M | $118M | $-9M | $-6M | $24M | $-12M | $-15M | $-42M | $82M | $-85M | $-42M | $-9M | $32M | $-34M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | · | $215M | · | · | · | $-10M | · | · | · | $13M | · | · | · | $39M | · | · | |
| Operating Cash Flow | $269M | $526M | $294M | $660M | $303M | $184M | $301M | $200M | $279M | $209M | $134M | $269M | $190M | $155M | $132M | $293M | |
| CapEx | $85M | $77M | $102M | $80M | $94M | $87M | $125M | $111M | $66M | $57M | $52M | $50M | $59M | $75M | $64M | $108M | |
| Investing Cash Flow | $330M | $-298M | $307M | $193M | $-64M | $100M | $-304M | $210M | $-189M | $75M | $415M | $-180M | $-556M | $-187M | $-194M | $229M | |
| Stock Issued | $0 | $13M | $0 | $14M | $0 | $14M | $0 | $15M | $0 | $13M | $0 | $14M | $0 | $12M | $0 | $12M | |
| Stock Repurchased | · | · | $313M | $187M | · | · | $0 | $750M | · | · | $500M | $0 | · | · | $0 | $558M | |
| Net Stock Activity | · | $13M | · | · | · | $14M | · | · | · | $13M | · | · | · | $12M | · | · | |
| Financing Cash Flow | $-607M | $-25M | $-1.52B | $-175M | $-2M | $12M | $-2M | $-736M | $-1M | $5M | $-632M | $-637M | $940M | $11M | $-1M | $-552M | |
| Net Change in Cash | $-13M | $199M | $-918M | $677M | $254M | $299M | $-15M | $-318M | $88M | $285M | $-77M | $-551M | $572M | $-19M | $-56M | $-37M | |
| Free Cash Flow | · | $449M | · | · | · | $97M | · | · | · | $152M | · | · | · | $81M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $147M | · | · | · | $77M | · | · |
Redditività 8
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.4% | 62.9% | · | 60.5% | 59.5% | 56.9% | · | 59.7% | 62.4% | 61.0% | · | 63.9% | 62.7% | 62.4% | · | 64.2% | |
| Operating Margin | 24.3% | 21.4% | · | 20.1% | 18.4% | 12.9% | · | 15.3% | 15.7% | 11.0% | · | 21.1% | 14.7% | 6.4% | · | 19.2% | |
| Net Margin | 19.0% | 16.7% | · | 23.5% | 15.5% | 10.2% | · | 13.5% | 14.3% | 15.9% | · | 12.4% | 13.3% | 6.6% | · | 13.2% | |
| Pretax Margin | 24.3% | 22.6% | · | 29.1% | 20.8% | 14.9% | · | 17.8% | 18.7% | 14.4% | · | 24.7% | 18.3% | 8.7% | · | 19.0% | |
| EBITDA Margin | 29.5% | 27.1% | · | 25.3% | 23.8% | 18.7% | · | 15.3% | 15.7% | 16.7% | · | 21.1% | 14.7% | 12.0% | · | 19.2% | |
| ROA | 3.6% | 3.0% | · | 4.1% | 2.5% | 1.6% | · | 2.1% | 2.1% | 2.4% | · | 2.1% | 1.9% | 0.92% | · | 2.1% | |
| ROE | 9.6% | 7.6% | · | 12.1% | 7.2% | 4.7% | · | 6.3% | 6.3% | 6.5% | · | 5.9% | 5.3% | 2.2% | · | 5.1% | |
| ROIC | 9.5% | 6.4% | · | 7.2% | 6.2% | 4.0% | · | 5.8% | 5.0% | 5.0% | · | 4.5% | 4.4% | 1.6% | · | 5.6% |
Liquidità e Solvibilità 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.6 | 1.5 | 1.5 | · | 2.5 | 2.8 | 2.9 | · | 2.8 | 2.4 | 2.0 | · | 3.8 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.9 | 0.8 | 0.7 | · | 0.9 | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.7 | · | 1.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 22.0 | · | 41.9 | 21.7 | 10.3 | · | 32.1 |
Efficienza 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.8 | 0.8 | · | 0.7 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.8 | · | 0.8 | |
| Receivables Turnover | 1.0 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.1 | 1.2 | 1.1 | · | 1.4 | 1.3 | 1.3 | · | 1.4 |
Valutazione (TTM) 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.87B | $4.59B | · | $4.40B | $4.19B | $3.96B | · | $3.89B | $3.77B | $3.51B | · | $3.36B | $3.08B | $2.84B | · | $2.74B | |
| Net Income TTM | $912M | $768M | · | $704M | $563M | $530M | · | $545M | $526M | $432M | · | $386M | $317M | $298M | · | $337M | |
| Market Cap | $25.42B | $24.23B | · | $26.24B | $34.24B | $26.78B | · | $26.19B | $45.43B | $54.94B | · | $36.05B | $49.62B | $45.03B | · | $31.10B | |
| P/E | 29.3 | 32.5 | · | 38.2 | 61.9 | 51.7 | · | 50.0 | 88.6 | 132.1 | · | 100.3 | 169.1 | 163.6 | · | 100.7 | |
| P/S | 5.2 | 5.3 | · | 6.0 | 8.2 | 6.8 | · | 6.7 | 12.0 | 15.7 | · | 10.7 | 16.1 | 15.9 | · | 11.3 | |
| P/B | 9.7 | 8.2 | · | 9.6 | 13.3 | 11.8 | · | 13.2 | 18.7 | 24.5 | · | 15.9 | 23.6 | 20.2 | · | 17.0 | |
| P / Tangible Book | 10.2 | 8.4 | · | 10.0 | 13.9 | 12.5 | · | 14.2 | 19.8 | 26.2 | · | 17.2 | 25.8 | 22.0 | · | 17.5 | |
| P / Cash Flow | · | 46.1 | · | · | · | 145.7 | · | · | · | 262.6 | · | · | · | 289.8 | · | · | |
| P / FCF | · | 54.0 | · | · | · | 276.6 | · | · | · | 360.7 | · | · | · | 558.0 | · | · | |
| Earnings Yield | 3.4% | 3.1% | · | 2.6% | 1.6% | 1.9% | · | 2.0% | 1.1% | 0.76% | · | 1.0% | 0.59% | 0.61% | · | 0.99% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B |
| Margine Lordo % | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% |
| Margine Operativo % | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% |
| Utile netto | $836M | $576M | $542M | $341M | $217M |
| EPS Diluito | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 |
| Quick Ratio | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $1.08B | $631M | $512M | $305M | $53M |
Ultime notizie Notizie recenti che menzionano questa società
Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 1.087 filer · $16.0B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 131 (-28 vs trimestre precedente) | 96 (+4 vs trimestre precedente) | 386 (+17 vs trimestre precedente) | 352 (+6 vs trimestre precedente) | +42.0M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.697.876.797 | 25.209.752 | 10,61% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.323.867.969 | 19.656.540 | 8,27% | Azioni |
| STATE STREET CORP | $1.237.947.284 | 18.380.806 | 7,73% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $751.533.926 | 11.199.611 | 4,70% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $734.346.085 | 11.693.409 | 4,59% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $545.031.559 | 8.092.525 | 3,41% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $462.914.937 | 6.873.273 | 2,89% | Azioni |
| NORGES BANK | $462.565.862 | 6.868.090 | 2,89% | Azioni |
| Castle Hook Partners LP | $260.667.534 | 3.870.342 | 1,63% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $231.614.091 | 3.438.962 | 1,45% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $206.860.340 | 3.071.423 | 1,29% | Azioni |
| JANUS HENDERSON GROUP PLC | $162.720.013 | 2.591.083 | 1,02% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $152.790.681 | 2.268.607 | 0,95% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $149.327.006 | 2.217.179 | 0,93% | Azioni |
| Employees Provident Fund Board | $147.498.453 | 2.190.029 | 0,92% | Azioni |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $129.989.908 | 2.069.903 | 0,81% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $114.711.656 | 1.703.218 | 0,72% | Azioni |
| BLAIR WILLIAM & CO/IL | $112.182.565 | 1.665.665 | 0,70% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $109.834.111 | 1.630.796 | 0,69% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $102.869.971 | 1.527.394 | 0,64% | Azioni |
| BANK OF AMERICA CORP /DE/ | $97.103.277 | 1.441.771 | 0,61% | Azioni |
| AMERIPRISE FINANCIAL INC | $93.336.259 | 1.385.802 | 0,58% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $92.130.221 | 1.367.932 | 0,58% | Azioni |
| DSM CAPITAL PARTNERS LLC | $91.537.742 | 1.359.135 | 0,57% | Azioni |
| Mitsubishi UFJ Asset Management Co., Ltd. | $89.939.931 | 1.335.411 | 0,56% | Azioni |
| ROYAL BANK OF CANADA | $88.321.000 | 1.311.368 | 0,55% | Azioni |
| GOLDMAN SACHS GROUP INC | $87.360.493 | 1.297.112 | 0,55% | Azioni |
| CI INVESTMENTS INC. | $86.724.103 | 1.287.663 | 0,54% | Azioni |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $85.826.193 | 1.274.331 | 0,54% | Azioni |
| BANK OF NOVA SCOTIA | $85.283.937 | 1.266.285 | 0,53% | Azioni |
| DNB Asset Management AS | $84.543.377 | 1.255.284 | 0,53% | Azioni |
| Nearwater Capital Markets, Ltd | $84.187.500 | 1.250.000 | 0,53% | Azioni |
| Stephens Investment Management Group LLC | $81.126.645 | 1.204.553 | 0,51% | Azioni |
| Swedbank AB | $78.528.215 | 1.165.972 | 0,49% | Azioni |
| BlackRock, Inc. | $77.389.460 | 1.149.064 | 0,48% | Azioni |
| FMR LLC | $77.274.023 | 1.147.350 | 0,48% | Azioni |
| CITADEL ADVISORS LLC | $75.864.589 | 1.126.423 | 0,47% | Azioni |
| FIRST TRUST ADVISORS LP | $74.838.523 | 1.111.188 | 0,47% | Azioni |
| HSBC HOLDINGS PLC | $73.861.872 | 1.080.800 | 0,46% | Opzione Call |
| Swiss National Bank | $73.108.425 | 1.085.500 | 0,46% | Azioni |
| CANADA PENSION PLAN INVESTMENT BOARD | $71.040.241 | 1.054.792 | 0,44% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $67.343.265 | 999.900 | 0,42% | Azioni |
| CITADEL ADVISORS LLC | $64.656.000 | 960.000 | 0,40% | Opzione Put |
| Legal & General Group Plc | $64.638.083 | 959.734 | 0,40% | Azioni |
| Sumitomo Mitsui Trust Group, Inc. | $64.478.600 | 957.366 | 0,40% | Azioni |
| BAILLIE GIFFORD & CO | $63.928.755 | 949.202 | 0,40% | Azioni |
| CIBC Bancorp USA Inc. | $62.958.645 | 932.286 | 0,39% | Azioni |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $61.865.555 | 918.568 | 0,39% | Azioni |
| PRINCIPAL FINANCIAL GROUP INC | $59.044.465 | 876.681 | 0,37% | Azioni |
| Chicago Capital, LLC | $58.393.062 | 867.009 | 0,36% | Azioni |
| Fisher Funds Management LTD | $56.637.983 | 840.950 | 0,35% | Azioni |
| Vanguard Global Advisers, LLC | $56.107.871 | 833.079 | 0,35% | Azioni |
| JANE STREET GROUP, LLC | $56.062.140 | 832.400 | 0,35% | Opzione Call |
| Bellevue Group AG | $55.394.634 | 822.489 | 0,35% | Azioni |
| Tri Locum Partners LP | $55.259.261 | 820.479 | 0,35% | Azioni |
| RHUMBLINE ADVISERS | $51.735.803 | 768.165 | 0,32% | Azioni |
| ENVESTNET ASSET MANAGEMENT INC | $51.168.667 | 759.743 | 0,32% | Azioni |
| UBS Group AG | $51.066.858 | 758.231 | 0,32% | Azioni |
| Allianz Asset Management GmbH | $50.820.963 | 809.251 | 0,32% | Azioni |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $50.518.000 | 750.088 | 0,32% | Azioni |
| BARCLAYS PLC | $50.351.331 | 747.607 | 0,31% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $49.968.851 | 741.928 | 0,31% | Azioni |
| TWO SIGMA ADVISERS, LP | $49.649.804 | 748.076 | 0,31% | Azioni |
| Smith Group Asset Management, LLC | $47.235.720 | 701.347 | 0,30% | Azioni |
| NATIONAL BANK OF CANADA /FI/ | $46.761.576 | 694.307 | 0,29% | Azioni |
| Assenagon Asset Management S.A. | $46.716.317 | 693.635 | 0,29% | Azioni |
| NEUBERGER BERMAN GROUP LLC | $46.117.886 | 684.750 | 0,29% | Azioni |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $44.760.810 | 664.600 | 0,28% | Azioni |
| PEREGRINE CAPITAL MANAGEMENT LLC | $44.759.530 | 664.581 | 0,28% | Azioni |
| Capital International Investors | $44.585.633 | 661.999 | 0,28% | Azioni |
| CAPITAL FUND MANAGEMENT S.A. | $44.543.875 | 661.379 | 0,28% | Azioni |
| Pictet Asset Management Holding SA | $44.534.379 | 661.238 | 0,28% | Azioni |
| National Pension Service | $44.471.811 | 660.309 | 0,28% | Azioni |
| California Public Employees Retirement System | $42.988.899 | 638.291 | 0,27% | Azioni |
| Korea Investment CORP | $42.608.237 | 632.639 | 0,27% | Azioni |
| ING GROEP NV | $41.334.513 | 613.727 | 0,26% | Azioni |
| Susquehanna Portfolio Strategies, LLC | $41.226.753 | 612.127 | 0,26% | Azioni |
| MIG Capital, LLC | $40.190.154 | 605.547 | 0,25% | Azioni |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $39.472.718 | 584.004 | 0,25% | Azioni |
| Quantinno Capital Management LP | $39.303.248 | 583.567 | 0,25% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $36.898.831 | 587.561 | 0,23% | Azioni |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $36.855.267 | 547.220 | 0,23% | Azioni |
| FACTORY MUTUAL INSURANCE CO | $36.222.851 | 537.830 | 0,23% | Azioni |
| Woodline Partners LP | $36.146.880 | 536.702 | 0,23% | Azioni |
| Parkman Healthcare Partners LLC | $36.016.557 | 534.767 | 0,23% | Azioni |
| MARSHALL WACE, LLP | $35.884.349 | 532.804 | 0,22% | Azioni |
| Walleye Trading LLC | $35.823.465 | 531.900 | 0,22% | Opzione Call |
| EVENTIDE ASSET MANAGEMENT, LLC | $33.574.377 | 498.202 | 0,21% | Azioni |
| Blue Sparrow, LLC /DE | $32.368.410 | 480.600 | 0,20% | Azioni |
| Trexquant Investment LP | $31.938.380 | 474.215 | 0,20% | Azioni |
| Cubist Systematic Strategies, LLC | $31.905.647 | 474.151 | 0,20% | Azioni |
| UBS Group AG | $31.896.960 | 473.600 | 0,20% | Opzione Put |
| Mitsubishi UFJ Trust & Banking Corp | $31.227.164 | 463.655 | 0,20% | Azioni |
| USS Investment Management Ltd | $30.910.132 | 459.050 | 0,19% | Azioni |
| OFI INVEST ASSET MANAGEMENT | $29.454.211 | 500.000 | 0,18% | Azioni |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $29.397.534 | 436.489 | 0,18% | Azioni |
| ProShare Advisors LLC | $28.566.636 | 424.152 | 0,18% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $28.528.135 | 427.840 | 0,18% | Azioni |
| SIRIOS CAPITAL MANAGEMENT L P | $28.315.152 | 420.418 | 0,18% | Azioni |
| Bridgewater Associates, LP | $27.002.568 | 400.929 | 0,17% | Azioni |
Insider aziendali 60 insider · 36 dirigenti · 23 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jacob Steven Leach | President, CEO, and Director | 22 Maggio 2026 F | 420.359 | 2 | 0 | $1.001.761 |
| Andrew P Rasdal | President & CEO | 02 Maggio 2006 M | 2.944 | 0 | 0 | $0 |
| Jess Roper | SVP, CFO | 22 Marzo 2017 S | 8.452 | 0 | 0 | $0 |
| Steven J Kemper | Chief Financial Officer | 15 Maggio 2007 A | 26.255 | 0 | 0 | $0 |
| Quentin S. Blackford | Chief Operating Officer | 10 Settembre 2021 S | 19.280 | 0 | 0 | $0 |
| Kevin R Sayer | Executive Chair | 20 Luglio 2026 S | 328.970 | 0 | 3 | $-5.895.098 |
| Jon Coleman | EVP, Chief Commercial Officer | 04 Giugno 2026 S | 95.450 | 0 | 2 | $-722.628 |
| Sadie Stern | EVP Chief People & Culture Off | 22 Maggio 2026 F | 130.059 | 0 | 1 | $-117.280 |
| Jereme M Sylvain | EVP, Chief Financal Officer | 22 Maggio 2026 F | 151.841 | 0 | 1 | $-357.796 |
| Matthew Vincent Dolan | EVP, Strategy & Corporate Dev | 29 Gennaio 2025 S | 42.044 | 0 | 0 | $0 |
| Teri L Lawver | EVP Chief Commercial Officer | 12 Marzo 2024 S | 66.641 | 0 | 0 | $0 |
| Paul R Flynn | EVP Global Revenue | 18 Dicembre 2023 D | 48.949 | 0 | 0 | $0 |
| Barry J. Regan | EVP Operations | 18 Dicembre 2023 D | 58.469 | 0 | 0 | $0 |
| Steven Robert Pacelli | EVP Managing Director Dexcom V | 24 Novembre 2023 S | 124.775 | 0 | 0 | $0 |
| Girish Naganathan | EVP Chief Technology Officer | 09 Novembre 2023 S | 47.725 | 0 | 0 | $0 |
| Shelly Ramasamy Selvaraj | SVP Chief Information Officer | 11 Settembre 2023 D | 48.453 | 0 | 0 | $0 |
| Donald Abbey | EVP Global Business Services I | 10 Marzo 2023 D | 208.023 | 0 | 0 | $0 |
| Andrew K Balo | EVP Regulatory Strategy Clinic | 10 Marzo 2023 D | 50.908 | 0 | 0 | $0 |
| Chad Patterson | EVP Global Marketing | 09 Maggio 2022 S | 13.675 | 0 | 0 | $0 |
| Sumi Shrishrimal | SVP Chief Risk Officer | 09 Marzo 2022 D | 13.789 | 0 | 0 | $0 |
| Patrick Michael Murphy | EVP, Chief Legal Officer | 09 Settembre 2021 S | 16.254 | 0 | 0 | $0 |
| Richard Doubleday | EVP Chief Commercial Officer | 23 Marzo 2021 S | 6.654 | 0 | 0 | $0 |
| Jeffrey Moy | EVP Operations | 09 Settembre 2020 D | 34.784 | 0 | 0 | $0 |
| Heather S Ace | SVP Human Resources | 11 Marzo 2020 S | 38.584 | 0 | 0 | $0 |
| Terrance H Gregg | Executive Chairman | 16 Luglio 2018 S | 50.882 | 0 | 0 | $0 |
| John Lister | General Manager, EMEA | 09 Marzo 2017 M | 84.034 | 0 | 0 | $0 |
| Peter Gerhardsson | VP, Int'l Bus. Dev. | 16 Novembre 2010 P | 3.387 | 0 | 0 | $0 |
| David Carner | VP, Quality Assurance | 16 Agosto 2010 A | — | 0 | 0 | $0 |
| Laura Johnson | V.P., Intellectual Property | 12 Marzo 2010 A | — | 0 | 0 | $0 |
| Richard Yang | V.P., Strategic Affairs | 12 Marzo 2010 A | — | 0 | 0 | $0 |
| Claudia Graham | VP Marketing | 12 Marzo 2010 A | 18.741 | 0 | 0 | $0 |
| Rodney L Kellogg | Vice President of Sales | 19 Maggio 2008 A | — | 0 | 0 | $0 |
| James H Brauker | VP Research & Development | 24 Marzo 2008 A | 53.125 | 0 | 0 | $0 |
| Mark Brister | VP, Advanced Development Team | 02 Novembre 2007 A | 10.967 | 0 | 0 | $0 |
| John Riolo | VP of Quality Assurance | 02 Agosto 2007 A | — | 0 | 0 | $0 |
| Tae Andrews | Vice President of Marketing | 09 Marzo 2007 A | — | 0 | 0 | $0 |
| Mark G Foletta | Direttore | 03 Agosto 2026 S | 48.852 | 0 | 4 | $-627.183 |
| Albert Frederick Osterloh IV | Direttore | 28 Maggio 2026 A | 8.691 | 0 | 0 | $0 |
| Euan A. Ashley | Direttore | 28 Maggio 2026 A | 12.731 | 0 | 0 | $0 |
| Rimma Driscoll | Direttore | 28 Maggio 2026 A | 17.319 | 0 | 0 | $0 |
| Kyle Malady | Direttore | 28 Maggio 2026 A | 28.242 | 0 | 1 | $-53.934 |
| Richard Alexander Collins | Direttore | 28 Maggio 2026 A | 5.605 | 0 | 2 | $-389.410 |
| Renee D Gala | Direttore | 28 Maggio 2026 A | 12.486 | 0 | 0 | $0 |
| Steven R Altman | Direttore | 28 Maggio 2026 A | 5.565 | 0 | 0 | $0 |
| Karen M Dahut | Direttore | 08 Maggio 2025 G | 17.779 | 0 | 0 | $0 |
| Eric Topol | Direttore | 08 Maggio 2025 G | 380.545 | 0 | 0 | $0 |
| Barbara Kahn | Direttore | 18 Maggio 2024 G | 22.575 | 0 | 0 | $0 |
| Jay S Skyler | Direttore | 18 Maggio 2023 G | 63.348 | 0 | 0 | $0 |
| Jonathan T Lord MD | Direttore | 01 Settembre 2016 S | 52.820 | 0 | 0 | $0 |
| Martin Doordan | Direttore | 01 Giugno 2012 A | 39.633 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 197 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| TMFM · RBB Fund, Inc. | 5,18% | 81.981 NS | 31 Maggio 2026 | N-PORT |
| HEAL · Global X Funds | 4,89% | 16.599 NS | 31 Maggio 2026 | N-PORT |
| SNSR · Global X Funds | 4,74% | 161.491 NS | 31 Maggio 2026 | N-PORT |
| IHI · iShares Trust | 4,54% | 1.828.483 SH | 08 Agosto 2026 | Giornaliero |
| GDOC · Goldman Sachs ETF Trust | 2,79% | 7.621 NS | 31 Maggio 2026 | N-PORT |
| TMFG · RBB Fund, Inc. | 2,33% | 112.503 NS | 31 Maggio 2026 | N-PORT |
| AGNG · Global X Funds | 2,01% | 22.316 NS | 31 Maggio 2026 | N-PORT |
| HRTS · Tema ETF Trust | 1,92% | 13.512 NS | 31 Maggio 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 1,91% | 5.848 NS | 30 Aprile 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1,89% | 952 NS | 30 Aprile 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,72% | 158.549 SH | 08 Agosto 2026 | Giornaliero |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,42% | 389.654 SH | 08 Agosto 2026 | Giornaliero |
| TMFX · RBB Fund, Inc. | 1,37% | 5.955 NS | 31 Maggio 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,18% | 6.533 NS | 31 Maggio 2026 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 1,17% | 15.853 NS | 31 Maggio 2026 | N-PORT |
| DTEC · ALPS ETF Trust | 1,01% | 10.206 NS | 31 Maggio 2026 | N-PORT |
| QGRO · AMERICAN CENTURY ETF TRUST | 1,01% | 302.231 NS | 31 Maggio 2026 | N-PORT |
| LGRO · ALPS ETF Trust | 1,00% | 18.376 NS | 31 Maggio 2026 | N-PORT |
| QQQG · Pacer Funds Trust | 0,99% | 1.867 NS | 30 Aprile 2026 | N-PORT |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 0,97% | 17.329 NS | 30 Aprile 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 0,92% | 6.459 NS | 30 Aprile 2026 | N-PORT |
| MMID · MFS Active Exchange Traded Funds Tr… | 0,91% | 4.208 NS | 31 Maggio 2026 | N-PORT |
| IWP · iShares Trust | 0,91% | 2.217.346 SH | 08 Agosto 2026 | Giornaliero |
| SDG · iShares Trust | 0,87% | 18.232 SH | 08 Agosto 2026 | Giornaliero |
| MEDI · Harbor ETF Trust | 0,84% | 3.888 NS | 30 Aprile 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 0,80% | 163.528 NS | 30 Aprile 2026 | N-PORT |
| FWD · AB Active ETFs, Inc. | 0,76% | 296.418 NS | 31 Maggio 2026 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0,67% | 56.679 NS | 31 Maggio 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,64% | 1.196 NS | 30 Aprile 2026 | N-PORT |
| QNXT · iShares Trust | 0,59% | 2.014 SH | 08 Agosto 2026 | Giornaliero |
| VOT · VANGUARD INDEX FUNDS | 0,57% | 2.956.203 SH | 08 Agosto 2026 | Giornaliero |
| IYH · iShares Trust | 0,52% | 229.458 SH | 08 Agosto 2026 | Giornaliero |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,46% | 1.074.035 SH | 08 Agosto 2026 | Giornaliero |
| IMCG · iShares Trust | 0,43% | 209.424 SH | 08 Agosto 2026 | Giornaliero |
| RXL · ProShares Trust | 0,41% | 4.013 NS | 31 Maggio 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0,41% | 2.617 NS | 30 Aprile 2026 | N-PORT |
| IXJ · iShares Trust | 0,40% | 202.443 SH | 08 Agosto 2026 | Giornaliero |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,38% | 56.496 NS | 30 Aprile 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,38% | 1.156.710 SH | 08 Agosto 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,38% | 179.798 NS | 30 Aprile 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,34% | 23.742 SH | 08 Agosto 2026 | Giornaliero |
| MMLG · First Trust Exchange-Traded Fund VI… | 0,33% | 4.233 NS | 31 Maggio 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,33% | 18.233 NS | 31 Maggio 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,33% | 7.675 NS | 30 Aprile 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,32% | 11.239 NS | 31 Maggio 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,32% | 9.251 NS | 31 Maggio 2026 | N-PORT |
| AVLV · AMERICAN CENTURY ETF TRUST | 0,32% | 558.304 NS | 31 Maggio 2026 | N-PORT |
| TMFE · RBB Fund, Inc. | 0,32% | 3.671 NS | 31 Maggio 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,30% | 64.292 NS | 30 Aprile 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0,26% | 7.662 NS | 31 Maggio 2026 | N-PORT |